UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

President Donald Trump signs a sweeping executive order aimed at drastically reducing prescription drug prices in the United ...

The head of UnitedHealth Group is stepping down, ending a rocky four years marked by rising medical costs, a major ...

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescripti ...

Blue-chip health insurer UnitedHealth (UNH) is weighing on the Dow today after a suspended guidance and C-suite shakeup ...

Less than a month after a dramatic cut to UnitedHealth Group’s guidance set off a historic selloff in the insurance giant’s ...

Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug ...

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group's CEO from 2006 to ...

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...

UnitedHealth Group announced the surprise exit of CEO Andrew Witty on Tuesday and suspended its 2025 forecast due to surging ...

Cigna’s stock slipped over 5% on a day the S&P 500 soared, thanks to a bold move by President Trump targeting pharmacy ...